Elevation Oncology Inc
NASDAQ:ELEV

Watchlist Manager
Elevation Oncology Inc Logo
Elevation Oncology Inc
NASDAQ:ELEV
Watchlist
Price: 0.365 USD -2.12% Market Closed
Market Cap: 21.6m USD

Operating Margin
Elevation Oncology Inc

0%
Current
0%
Average
-4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-45.7m
/
Revenue
0

Operating Margin Across Competitors

No Stocks Found

Elevation Oncology Inc
Glance View

Market Cap
21.6m USD
Industry
Biotechnology

Elevation Oncology, Inc. operates as a precision oncology company. The company is headquartered in New York City, New York and currently employs 35 full-time employees. The company went IPO on 2021-06-25. The firm is focused on the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations. The company focuses on identifying oncogenic drivers with other driver alterations and in the conduct of clinical trials. Its lead drug development candidate, seribantumab, is an Anti-HER3 monoclonal antibody and potential targeted therapy for solid tumors driven by neuregulin-1 (NRG1) fusions, which are genomic alterations that are identified as oncogenic driver alterations. Its NRG1 is the primary activating ligand of HER3. The firm's clinical trial, CRESTONE, is a Phase II study of seribantumab in cancer patients with a solid tumor of any origin that expresses a genomic change called an NRG1 fusion.

ELEV Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-45.7m
/
Revenue
0
What is the Operating Margin of Elevation Oncology Inc?

Based on Elevation Oncology Inc's most recent financial statements, the company has Operating Margin of 0%.

Back to Top